Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Diabetes, Obesity & Metabolism|November 21, 2024
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RAMengqing Zhang, Chu Lin, Xiaoling Cai, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 26, 2021
Effects of Electroacupuncture on Sleep via the Dopamine System of the HPA Axis in Rats after Cage ChangeChen Xie, Jing Wang, Na Zhao, et al.
Communications Medicine|June 5, 2026
Placebo response on the weight change and its influencing factors in overweight or obesity with or without diabetes: a meta-analysis of 182 anti-obesity medications trialsYuchen Guo, Wenjia Yang, Chu Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Community-based lung cancer screening with low-dose CT in China: Results of the baseline screeningWenjia Yang, Fangfei Qian, Jiajun Teng, et al.
Scientific Reports|December 8, 2025
Altered static and dynamic intrinsic brain activity patterns in type 2 diabetic patientsYongsheng Liang, Weiyin Vivian Liu, Mingrui Li, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 12, 2024
Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta-analysis of randomized clinical trialsWenjia Yang, Han Wu, Xiaoling Cai, et al.
Frontiers in Endocrinology|January 25, 2021
Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune ThyroiditisZhiyong Wu, Yu Zhu, Min Zhang, et al.
Iscience|September 25, 2024
The weight reduction mediated by anti-obesity medication and the cardiovascular outcomeYuchen Guo, Chu Lin, Xiaoling Cai, et al.
The Annals of Thoracic Surgery|November 24, 2018
Adjuvant Chemotherapy Improves Survival in Surgically Resected Stage IB Squamous Lung CancerJianlin Xu, Shuyuan Wang, Hua Zhong, et al.
Chinese Medical Journal|April 3, 2025
Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trialXiaoling Cai, Suiyuan Hu, Chu Lin, et al.
Pageof 15